Fact CheckerSign in

NCT02638142Recruiting

Loop Diuretic Therapy in Acutely Decompensated Heart Failure

Continuous Versus Bolus Intermittent Loop Diuretic Infusion in Acutely Decompensated Heart Failure: Evaluation of Renal Function, Congestion Signs, BNP and Outcome

Source: ClinicalTrials.gov · Last updated 8 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

DiurHF is a prospective, multicenter, observational, study that compares continuous with intermittent infusion of furosemide in patients admitted with a diagnosis of ADHF. Previous pilot study design was planned to anticipate a larger multicenter trial able to definitively evaluate the optimal loop diuretic use strategy in patients with ADHF.

Status (registry)
Recruiting
Study type
Observational
Enrollment
370 (estimated)
First submitted
9 Dec 2015
Start date
1 Dec 2015
Primary completion date
31 Jan 2028
Lead sponsor
University of Siena
NCT number
NCT02638142

What you commit to

  • Study type: Observational
  • Planned participants: 370
  • From 1 Dec 2015 to the primary completion date, 31 Jan 2028
  • 4 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • End-Stage renal disease or renal replacement therapy;
  • Recent myocardial infarction (within thirty days of screening);
  • Patients affected by sepsis, liver diseases, inflammatory diseases or neoplastic diseases.

Lab values

  • Creatinine levels \> 4 mg/dL;

Other

  • Patients who receive more than 40 mg of IV furosemide;
  • Systolic blood pressure \< 80 mmHg;

Who the study is looking for

  • Patients over 18 years;
  • Patients with diagnosis of ADHF(dyspnea, orthopnea, peripheral edema or major fatigue and at least two clinical signs including rales, hepatomegaly, pulmonary congestion on chest radiography, jugular vein dilatation, or a third heart sound);
  • Blood BNP \> 100 pg/mL;
    • ADHF: Acute Decompensated Heart Failure; BNP: B-type Natriuretic Peptide; IV: IntraVenous; LVEF: Left Ventricular Ejection Fraction.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (4)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ospedale Madonna della Navicella
Coordinator of this site? Confirm its status
ChioggiaItalyRecruiting
Azienda Ospedaliera di Padova
Coordinator of this site? Confirm its status
PadovaItalyRecruiting
University of Rome La Sapienza
Coordinator of this site? Confirm its status
RomaItalyRecruiting
Department of Internal Medicine, Cardiovascular Diseases Unit
Coordinator of this site? Confirm its status
SienaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.